Book contents
- Clinical Reasoning and Decision-Making in Psychiatry
- Reviews
- Clinical Reasoning and Decision-Making in Psychiatry
- Copyright page
- Contents
- Foreword
- Preface
- 1 Making Sense of the Senseless: How to Gather and Organize Pertinent Information
- 2 The Approach to Diagnostic Ambiguity
- 3 What the Patient Isn’t Telling You: When Seeing Is Not Believing
- 4 Shared Decision-Making
- 5 Deciding on Appropriate Treatment Modalities: Medication, Psychotherapy, Hospitalization, and Other Levels of Care
- 6 Measurement-Based Care and Applying Statistical Concepts to the Individual Patient
- 7 Hypothesis-Testing and Crafting Patient-Specific Decision Trees
- 8 Decision Points in Iterative Pharmacotherapy
- 9 Hierarchical and Complex Pharmacotherapy Decision-Making
- 10 Prioritizing the Components of Any Decision-Making Model
- Index
- References
7 - Hypothesis-Testing and Crafting Patient-Specific Decision Trees
Published online by Cambridge University Press: 25 March 2024
Book contents
- Clinical Reasoning and Decision-Making in Psychiatry
- Reviews
- Clinical Reasoning and Decision-Making in Psychiatry
- Copyright page
- Contents
- Foreword
- Preface
- 1 Making Sense of the Senseless: How to Gather and Organize Pertinent Information
- 2 The Approach to Diagnostic Ambiguity
- 3 What the Patient Isn’t Telling You: When Seeing Is Not Believing
- 4 Shared Decision-Making
- 5 Deciding on Appropriate Treatment Modalities: Medication, Psychotherapy, Hospitalization, and Other Levels of Care
- 6 Measurement-Based Care and Applying Statistical Concepts to the Individual Patient
- 7 Hypothesis-Testing and Crafting Patient-Specific Decision Trees
- 8 Decision Points in Iterative Pharmacotherapy
- 9 Hierarchical and Complex Pharmacotherapy Decision-Making
- 10 Prioritizing the Components of Any Decision-Making Model
- Index
- References
Summary
Formulating and empirically testing hypotheses lies at the core of the scientific method, and is a cornerstone for practicing evidence-based medicine – especially if and when the evidence base for a given problem may not yet be so well developed in the literature. Whether we realize it or not, every clinical encounter is essentially the buildup to generating a hypothesis – a framework for explaining how and why a set of problems arose, and then figuring out whether the available information supports or refutes the proposed explanation. A hypothesis is a testable, falsifiable question posed about the association between two variables.
- Type
- Chapter
- Information
- Clinical Reasoning and Decision-Making in Psychiatry , pp. 177 - 208Publisher: Cambridge University PressPrint publication year: 2024
References
Altshuler, LL, Keck, PE Jr., McElroy, SL, et al.Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1999; 1: 61–65CrossRefGoogle ScholarPubMed
Cole, EJ, Stimpson, KH, Bentzley, GS, et al.Stanford Accelerated Intelligent Neuromodulation Therapy for treatment-resistant depression. Am J Psychiatry 2020; 177: 716–726CrossRefGoogle ScholarPubMed
Doherty, TS, Carroll, AE.Believing in overcoming cognitive biases. AMA J Ethics 2020; 22(9):E773–E778Google ScholarPubMed
Durgam, S, Gommoll, C, Forero, G, et al.Efficacy and safety of vilazodone in patients with generalized anxiety disorder: A randomized, double-blind, placebo-controlled, flexible-dose trial. J Clin Psychiatry 2016; 77: 1687–1694CrossRefGoogle ScholarPubMed
Faraone, SV, Wilens, TE.Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry 2007; 68 (suppl 11): 15–22CrossRefGoogle Scholar
Fava, M, Rush, AJ, Alpert, JE, et al.Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. Am J Psychiatry 2008; 165: 342–351CrossRefGoogle ScholarPubMed
Ferguson, JM, Tourian, KA, Rosas, GR.High-dose desvenlafaxine in outpatients with major depressive disorder. CNS Spectrums 2012; 17: 121–130CrossRefGoogle ScholarPubMed
Kushner, SF, Khan, A, Lane, R, et al.Topiramate monotherapy in the management of acute mania: Results of four double-blind placebo-controlled trials. Bipolar Disord 2006; 8: 15–27CrossRefGoogle ScholarPubMed
McIntyre, RS, Lophaven, S, Olsen, CK.A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol 2014; 17: 1557–1567CrossRefGoogle ScholarPubMed
Mohamed, S, Johnson, GR, Chen, P, et al.Effect of antidepressant switching vs. augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: The VAST-D randomized clinical trial. JAMA 2017; 318: 132–145CrossRefGoogle ScholarPubMed
Nierenberg, AA, DeCecco, LM.Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: A focus on treatment-resistant depression. J Clin Psychiatry 2001; 62 (suppl 16): 5–9Google ScholarPubMed
Pande, AC, Crockatt, JG, Janney, CA, et al.Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2: 249–255CrossRefGoogle ScholarPubMed
Papakostas, GI, Thase, ME, Fava, M, et al.Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiatry 2007; 62: 1217–1227CrossRefGoogle Scholar
Soares-Weiser, K, Maayan, N, Bergman, H, et al.First rank symptoms for schizophrenia. Cochrane Database Syst Rev 2015; 1: CD010653Google ScholarPubMed
Sysko, R, Walsh, BT.A systematic review of placebo response in studies of bipolar mania. J Clin Psychiatry 2007; 68: 1213–1217CrossRefGoogle ScholarPubMed
Thase, ME, Chen, D, Edwards, J, et al.Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder. Int Clin Psychopharmacol 2014; 29: 351–356CrossRefGoogle ScholarPubMed
Vieta, E, Sachs, G, Chang, D, et al.Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania. J Psychopharmacol 2021; 35: 971–982CrossRefGoogle ScholarPubMed
Yuvarajan, R, Yousufzai, NM.Mania induced by lithium augmentation. A case report. Br J Psychiatry 1988; 153: 828–830CrossRefGoogle ScholarPubMed